Milkfat, MFGM, microbiota and early nutrition as main discussed topics during the 49th Annual Meeting of ESPGHAN

Athens - Fri, 07/01/2016

ESPGHAN 2016, 49th Annual Meeting of The European Society for Paediatric Gastroenterology, Hepatology and Nutrition was held this year from 25 to 28th of May.

The Meeting was placed at the Megaron Athens International Conference Centre. More than 4,000 delegates from 105 countries around the world attended the event, and more than 50 organisations were represented within the exhibition.

ESPGHAN, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, is one of the world’s largest scientific communities. The society aims to promote the health of children and holds an annual meeting, bringing together medical and nutritional experts from Europe and beyond.

There were 23 symposia, 8 of which were related to Nutrition, as well as 5 out of the 16 sessions conducted. The main topics that have been addressed this year on Nutrition are Milkfat, Early Nutrition, Childhood Obesity, Gluten and Coeliac Disease or Microbiota, among others.

Four hundred ninety-one posters were presented, being 141 on Nutrition, 69 on Hepatology and 281 Gastroenterology.

Hero continues collaborating with the experts from the Umea University and sharing the results of Tumme study in every edition of this relevant annual meeting.  Two oral communications were presented by Tove Grip, member of the scientific team of the Umea University in Sweden. Plasma metabolome and serum lipid profile results in infants fed with a formula supplemented with milk fat globule membranes were presented. The authors concluded that feeding infants with this study formula had a significant effect on these parameters, which could play a role on cognitive development. The future objective would be to investigate more about the compounds in MFGM which can be responsible for these changes detected.

In addition, the participants of the event had the privilege of attending the lecture of Professor Dr. Olle Hernell, member of the Hero Scientific Advisory Board, on "Clinical benefits of feeding a MFGM fraction to infants and young children". The main results regarded how MFGM presence in infant formula affects positively the lipidome and metabolome in babies. MFGM is part of the Hero formulas composition in many countries worldwide. The scientific team of the Umea University and Hero presented for the first time the beneficial outcomes for babies during ESPGHAN Annual meeting in 2013: an Infant formula with MFGM showed beneficial effect on babies’ cognitive and immune systems.

Nowadays, Hero keeps publishing advances scientifically proven on infant formulas enriched with MFGM. For this reason, MFGM is revolutionising the current scenario of infant formula manufacturers. Hero’s innovation confirmed by science drives future trends!